These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15488758)

  • 1. TrkA alternative splicing: a regulated tumor-promoting switch in human neuroblastoma.
    Tacconelli A; Farina AR; Cappabianca L; Desantis G; Tessitore A; Vetuschi A; Sferra R; Rucci N; Argenti B; Screpanti I; Gulino A; Mackay AR
    Cancer Cell; 2004 Oct; 6(4):347-60. PubMed ID: 15488758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative TrkAIII splicing: a potential regulated tumor-promoting switch and therapeutic target in neuroblastoma.
    Tacconelli A; Farina AR; Cappabianca L; Gulino A; Mackay AR
    Future Oncol; 2005 Oct; 1(5):689-98. PubMed ID: 16556046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TrkA signal transduction pathways in neuroblastoma.
    Eggert A; Ikegaki N; Liu XG; Chou TT; Brodeur GM
    Med Pediatr Oncol; 2001 Jan; 36(1):108-10. PubMed ID: 11464858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular dissection of TrkA signal transduction pathways mediating differentiation in human neuroblastoma cells.
    Eggert A; Ikegaki N; Liu X; Chou TT; Lee VM; Trojanowski JQ; Brodeur GM
    Oncogene; 2000 Apr; 19(16):2043-51. PubMed ID: 10803465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuroblastoma tumour-suppressor TrkAI and its oncogenic alternative TrkAIII splice variant exhibit geldanamycin-sensitive interactions with Hsp90 in human neuroblastoma cells.
    Farina AR; Tacconelli A; Cappabianca L; Cea G; Chioda A; Romanelli A; Pensato S; Pedone C; Gulino A; Mackay AR
    Oncogene; 2009 Nov; 28(46):4075-94. PubMed ID: 19734938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acidic substitution of the activation loop tyrosines in TrkA supports nerve growth factor-dependent, but not nerve growth factor-independent, differentiation and cell cycle arrest in the human neuroblastoma cell line, SY5Y.
    Gryz EA; Meakin SO
    Oncogene; 2003 Nov; 22(54):8774-85. PubMed ID: 14647472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrograde TrkAIII transport from ERGIC to ER: a re-localisation mechanism for oncogenic activity.
    Farina AR; Cappabianca L; Ruggeri P; Gneo L; Maccarone R; Mackay AR
    Oncotarget; 2015 Nov; 6(34):35636-51. PubMed ID: 26415233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TrkAIII. A novel hypoxia-regulated alternative TrkA splice variant of potential physiological and pathological importance.
    Tacconelli A; Farina AR; Cappabianca L; Gulino A; Mackay AR
    Cell Cycle; 2005 Jan; 4(1):8-9. PubMed ID: 15611661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII.
    Farina AR; Cappabianca L; Ruggeri P; Gneo L; Pellegrini C; Fargnoli MC; Mackay AR
    J Exp Clin Cancer Res; 2018 Jun; 37(1):119. PubMed ID: 29914559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TrkAIII promotes microtubule nucleation and assembly at the centrosome in SH-SY5Y neuroblastoma cells, contributing to an undifferentiated anaplastic phenotype.
    Farina AR; Di Ianni N; Cappabianca L; Ruggeri P; Ragone M; Ianni G; Gulino A; Mackay AR
    Biomed Res Int; 2013; 2013():740187. PubMed ID: 23841091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The selective and inducible activation of endogenous PI 3-kinase in PC12 cells results in efficient NGF-mediated survival but defective neurite outgrowth.
    Ashcroft M; Stephens RM; Hallberg B; Downward J; Kaplan DR
    Oncogene; 1999 Aug; 18(32):4586-97. PubMed ID: 10467403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel cyclophane compound, CPPy, facilitates NGF-induced TrkA signal transduction and induces cell differentiation in neuroblastoma.
    Yamaguchi Y; Tabata K; Asami S; Miyake M; Suzuki T
    Biol Pharm Bull; 2007 Apr; 30(4):638-43. PubMed ID: 17409494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TrkAIII oncoprotein inhibits mitochondrial free radical ROS-induced death of SH-SY5Y neuroblastoma cells by augmenting SOD2 expression and activity at the mitochondria, within the context of a tumour stem cell-like phenotype.
    Ruggeri P; Farina AR; Di Ianni N; Cappabianca L; Ragone M; Ianni G; Gulino A; Mackay AR
    PLoS One; 2014; 9(4):e94568. PubMed ID: 24736663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NGF activation of TrkA decreases N-myc expression via MAPK path leading to a decrease in neuroblastoma cell number.
    Woo CW; Lucarelli E; Thiele CJ
    Oncogene; 2004 Feb; 23(8):1522-30. PubMed ID: 14691455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The alternative TrkAIII splice variant targets the centrosome and promotes genetic instability.
    Farina AR; Tacconelli A; Cappabianca L; Cea G; Panella S; Chioda A; Romanelli A; Pedone C; Gulino A; Mackay AR
    Mol Cell Biol; 2009 Sep; 29(17):4812-30. PubMed ID: 19564412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal proteomics of NGF-TrkA signaling identifies an inhibitory role for the E3 ligase Cbl-b in neuroblastoma cell differentiation.
    Emdal KB; Pedersen AK; Bekker-Jensen DB; Tsafou KP; Horn H; Lindner S; Schulte JH; Eggert A; Jensen LJ; Francavilla C; Olsen JV
    Sci Signal; 2015 Apr; 8(374):ra40. PubMed ID: 25921289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Src homology 2 domain protein Shb transmits basic fibroblast growth factor- and nerve growth factor-dependent differentiation signals in PC12 cells.
    Karlsson T; Kullander K; Welsh M
    Cell Growth Differ; 1998 Sep; 9(9):757-66. PubMed ID: 9751119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional expression of TrkA receptors in hippocampal neurons.
    Aibel L; Martin-Zanca D; Perez P; Chao MV
    J Neurosci Res; 1998 Nov; 54(3):424-31. PubMed ID: 9819147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and biological role of neurotrophin-receptor TrkA and TrkB in neuroblastoma.
    Eggert A; Ikegaki N; Liu XG; Brodeur GM
    Klin Padiatr; 2000; 212(4):200-5. PubMed ID: 10994551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nerve growth factor-induced protein kinase C stimulation contributes to TrkA-dependent inhibition of p75 neurotrophin receptor sphingolipid signaling.
    Plo I; Bono F; Bezombes C; Alam A; Bruno A; Laurent G
    J Neurosci Res; 2004 Aug; 77(4):465-74. PubMed ID: 15264216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.